← Back to Dashboard

Azvudine

Nucleoside reverse transcriptase inhibitor · RNA-dependent RNA polymerase inhibitor

2D Structure

Structure not available

3D Structure

Loading 3D structure...

Chemical Identifiers

PubChemClinicalTrials.govPubMed

Clinical Development by Virus2

Human immunodeficiency virus 1
HIV-1
Target: Viral RT
Approved (other)
Preclinical
Phase 2positive
Phase 3positive
Approved
China
Approval ref (english.nmpa.gov.cn) HenanGenuine BiotechNMPA approved July 2021 for HIVINN FNCPubChem CID 135398735
Approved (other)
Preclinical
Phase 2positive
Phase 3positive
Approved
China
Approval ref (english.nmpa.gov.cn) NMPA conditional approval July 2022 for COVID-19same compound as HIV INN FNC